Bafna Pharmaceuticals responded to NSE and BSE queries regarding significant share price movement on April 13, 2026.
The company stated it is unaware of any undisclosed information that could explain the price volatility.
Attributed the price movement to market-driven factors and general investor sentiment.
Confirmed full compliance with SEBI Listing Regulations disclosure requirements under Regulation 30.